Triple Helicase Activity and the Structural Basis of Collagenolysis

Biology of Extracellular Matrix

Volumn 2, Issue , 2011, Pages 95-122

  Nagase, Hideaki ^a   Visse, Robert ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Clostridium Histolyticum Collagenase; Collagen Fibril; Collagenolytic Activity; Fibrillar Collagen; Interstitial Collagen

Indexed keywords

EID: 84864506555     PISSN: 08873224     EISSN: 21911959     Source Type: Book Series    
DOI: 10.1007/978-3-642-16861-1_5     Document Type: Chapter

References (114)

1. Aimes RT, Quigley JP (1995) Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitorfree enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4-and 1/4-length fragments. J Biol Chem 270:5872–5876
2. Becker JW, Marcy AI, Rokosz LL, Axel MG, Burbaum JJ, Fitzgerald PM, Cameron PM, Esser CK, Hagmann WK, Hermes JD et al (1995) Stromelysin-1: three-dimensional structure of the inhibited catalytic domain and of the C-truncated proenzyme. Prot Sci 4:1966–1976
3. Bode W (1995) A helping hand for collagenases: the haemopexin-like domain. Structure 3: 527–530
4. Bode W, Maskos K (2003) Structural basis of the matrix metalloproteinases and their physiological inhibitors, the tissue inhibitors of metalloproteinases. Biol Chem 384:863–872
5. Br€omme D, Okamoto K, Wang BB, Biroc S (1996) Human cathepsin O2, a matrix proteindegrading cysteine protease expressed in osteoclasts. Functional expression of human cathepsin O2 in Spodoptera frugiperda and characterization of the enzyme. J Biol Chem 271:2126–2132
6. Brown RA, Hukins DW, Weiss JB, Twose TM (1977) Do mammalian collagenases and DNA restriction endonucleases share a similar mechanism for cleavage site recognition? Biochem Biophys Res Commun 74:1102–1108
7. Chung L, Shimokawa K, Dinakarpandian D, Grams F, Fields GB, Nagase H (2000) Identification of the (RWTNNFREY191)-R-183 region as a critical segment of matrix metalloproteinase 1 for the expression of collagenolytic activity. J Biol Chem 275:29610–29617
8. Chung L, Dinakarpandian D, Yoshida N, Lauer-Fields JL, Fields GB, Visse R, Nagase H (2004) Collagenase unwinds triple-helical collagen prior to peptide bond hydrolysis. EMBO J 23:3020–3030
9. Clark IM, Cawston TE (1989) Fragments of human fibroblast collagenase. Purification and characterization. Biochem J 263:201–206
10. Collier IE, Krasnov PA, Strongin AY, Birkedal-Hansen H, Goldberg GI (1992) Alanine scanning mutagenesis and functional analysis of the fibronectin-like collagen-binding domain from human 92-kDa type IV collagenase. J Biol Chem 267:6776–6781
11. de Souza SJ, Pereira HM, Jacchieri S, Brentani RR (1996) Collagen/collagenase interaction: does the enzyme mimic the conformation of its own substrate? FASEB J 10:927–930
12. Elkins PA, Ho YS, Smith WW, Janson CA, D’Alessio KJ, McQueney MS, Cummings MD, Romanic AM (2002) Structure of the C-terminally truncated human ProMMP9, a gelatinbinding matrix metalloproteinase. Acta Crystallogr D Biol Crystallogr 58:1182–1192
13. Ellerbroek SM, Wu YI, Overall CM, Stack MS (2001) Functional interplay between type I collagen and cell surface matrix metalloproteinase activity. J Biol Chem 276:24833–24842
14. Everts V, Hou WS, Rialland X, Tigchelaar W, Saftig P, Br€omme D, Gelb BD, Beertsen W (2003) Cathepsin K deficiency in pycnodysostosis results in accumulation of non-digested phagocytosed collagen in fibroblasts. Calcif Tissue Int 73:380–386
15. Fields GB (1991) A model for interstitial collagen catabolism by mammalian collagenases. J Theor Biol 153:585–602
16. Fiori S, Sacca B, Moroder L (2002) Structural properties of a collagenous heterotrimer that mimics the collagenase cleavage site of collagen type I. J Mol Biol 319:1235–1242
17. Fratzl-Zelman N, Valenta A, Roschger P, Nader A, Gelb BD, Fratzl P, Klaushofer K (2004) Decreased bone turnover and deterioration of bone structure in two cases of pycnodysostosis. J Clin Endocrinol Metab 89:1538–1547
18. Fridman R, Fuerst TR, Bird RE, Hoyhtya M, Oelkuct M, Kraus S, Komarek D, Liotta LA, Berman ML, Stetler-Stevenson WG (1992) Domain structure of human 72-kDa gelatinase/type IV collagenase. Characterization of proteolytic activity and identification of the tissue inhibitor of metalloproteinase-2 (TIMP-2) binding regions. J Biol Chem 267:15398–15405
19. Garnero P, Borel O, Byrjalsen I, Ferreras M, Drake FH, McQueney MS, Foged NT, Delmas PD, Delaissé JM (1998a) The collagenolytic activity of cathepsin K is unique among mammalian proteinases. J Biol Chem 273:32347–32352
20. Garnero P, Borel O, Byrjalsen I, Ferreras M, Drake FH, McQueney MS, Foged NT, Delmas PD, Delaisse JM (1998b) The collagenolytic activity of cathepsin K is unique among mammalian proteinases. J Biol Chem 273:32347–32352
21. Gelb BD, Shi GP, Chapman HA, Desnick RJ (1996) Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 273:1236–1238
22. Gioia M, Monaco S, Fasciglione GF, Coletti A, Modesti A, Marini S, Coletta M (2007) Characterization of the mechanisms by which gelatinase A, neutrophil collagenase, and membrane-type metalloproteinase MMP-14 recognize collagen I and enzymatically process the two alpha-chains. J Mol Biol 368:1101–1113
23. Gomis-R€uth FX, Gohlke U, Betz M, Kn€auper V, Murphy G, López-Otín C, Bode W (1996) The helping hand of collagenase-3 (MMP-13): 2.7 A crystal structure of its C-terminal haemopexin-like domain. J Mol Biol 264:556–566
24. Grams F, Reinemer P, Powers JC, Kleine T, Pieper M, Tschesche H, Huber R, Bode W (1995) X-ray structures of human neutrophil collagenase complexed with peptide hydroxamate and peptide thiol inhibitors. Implications for substrate binding and rational drug design. Eur J Biochem 228:830–841
25. Gross J, Lapiere CM (1962) Collagenolytic activity in amphibian tissues: a tissue culture assay. Proc Natl Acad Sci USA 48:1014–1022
26. Guo HM, Li RS, Zucker S, Toole BP (2000) EMMPRIN (CD147), an inducer of matrix metalloproteinase synthesis, also binds interstitial collagenase to the tumor cell surface. Cancer Res 60:888–891
27. Han S, Makareeva E, Kuznetsova NV, Deridder AM, Sutter MB, Losert W, Phillips CL, Visse R, Nagase H, Leikin S (2010) Molecular mechanism of type I collagen homotrimer resistance to mammalian collagenases. J Biol Chem 285:22276–22281
28. Hirose T, Patterson C, Pourmotabbed T, Mainardi CL, Hasty KA (1993) Structure-function relationship of human neutrophil collagenase: identification of regions responsible for substrate specificity and general proteinase activity. Proc Natl Acad Sci USA 90:2569–2573
29. Holmbeck K, Bianco P, Caterina J, Yamada S, Kromer M, Kuznetsov SA, Mankani M, Robey PG, Poole AR, Pidoux I, Ward JM, Birkedal-Hansen H (1999) MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 99:81–92
30. Hou WS, Br€omme D, Zhao Y, Mehler E, Dushey C, Weinstein H, Miranda CS, Fraga C, Greig F, Carey J, Rimoin DL, Desnick RJ, Gelb BD (1999) Characterization of novel cathepsin K mutations in the pro and mature polypeptide regions causing pycnodysostosis. J Clin Invest 103:731–738
31. Hummel KM, Petrow PK, Franz JK, Muller-Ladner U, Aicher WK, Gay RE, Br€omme D, Gay S (1998) Cysteine proteinase cathepsin K mRNA is expressed in synovium of patients with rheumatoid arthritis and is detected at sites of synovial bone destruction. J Rheumatol 25:1887–1894
32. Itoh Y, Ito A, Iwata K, Tanzawa K, Mori Y, Nagase H (1998) Plasma membrane-bound tissue inhibitor of metalloproteinases (TIMP)-2 specifically inhibits matrix metalloproteinase 2 (gelatinase A) activated on the cell surface. J Biol Chem 273:24360–24367
33. Itoh Y, Takamura A, Ito N, Maru Y, Sato H, Suenaga N, Aoki T, Seiki M (2001) Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion. EMBO J 20:4782–4793
34. Itoh Y, Ito N, Nagase H, Evans RD, Bird SA, Seiki M (2006) Cell surface collagenolysis requires homodimerization of the membrane-bound collagenase MT1-MMP. Mol Biol Cell 17:5390–5399
35. Jennison MW (1947) The collagenase activity of culture filtrates of Clostridium histolyticum. J Bacteriol 54:55
36. Jozic D, Bourenkov G, Lim NH, Visse R, Nagase H, Bode W, Maskos K (2005) X-ray structure of human proMMP-1: new insights into procollagenase activation and collagen binding. J Biol Chem 280:9578–9585
37. Jung CM, Matsushita O, Katayama S, Minami J, Sakurai J, Okabe A (1999) Identification of metal ligands in the Clostridium histolyticum ColH collagenase. J Bacteriol 181:2816–2822
38. Kafienah W, Br€omme D, Buttle DJ, Croucher LJ, Hollander AP (1998) Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix. Biochem J 331(Pt 3):727–732
39. Kn€auper V, Osthues A, DeClerck YA, Langley KE, Blaser J, Tschesche H (1993a) Fragmentation of human polymorphonuclear-leucocyte collagenase [see comments]. Biochem J 291:847–854
40. Kn€auper V, Wilhelm SM, Seperack PK, DeClerck YA, Langley KE, Osthues A, Tschesche H (1993b) Direct activation of human neutrophil procollagenase by recombinant stromelysin. Biochem J 295:581–586
41. Kn€auper V, López-Otín C, Smith B, Knight G, Murphy G (1996a) Biochemical characterization of human collagenase-3. J Biol Chem 271:1544–1550
42. Kn€auper V, Murphy G, Tschesche H (1996b) Activation of human neutrophil procollagenase by stromelysin 2. Eur J Biochem 235:187–191
43. Kn€auper V, Will H, López-Otín C, Smith B, Atkinson SJ, Stanton H, Hembry RM, Murphy G (1996c) Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase A (MMP-2) are able to generate active enzyme. J Biol Chem 271:17124–17131
44. Kn€auper V, Cowell S, Smith B, López-Otín C, O’Shea M, Morris H, Zardi L, Murphy G (1997a) The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction. J Biol Chem 272:7608–7616
45. Kn€auper V, Docherty AJP, Smith B, Tschesche H, Murphy G (1997b) Analysis of the contribution of the hinge region of human neutrophil collagenase (HNC, MMP-8) to stability and collagenolytic activity by alanine scanning mutagenesis. FEBS Lett 405:60–64
46. Kramer RZ, Bella J, Brodsky B, Berman HM (2001) The crystal and molecular structure of a collagen-like peptide with a biologically relevant sequence. J Mol Biol 311:131–147
47. Lauer-Fields JL, Chalmers MJ, Busby SA, Minond D, Griffin PR, Fields GB (2009) Identification of specific hemopexin-like domain residues that facilitate matrix metalloproteinase collagenolytic activity. J Biol Chem 284:24017–24024
48. Lee H, Overall CM, McCulloch CA, Sodek J (2006) A critical role for the membrane-type 1 matrix metalloproteinase in collagen phagocytosis. Mol Biol Cell 17:4812–4826
49. Leikina E, Mertts MV, Kuznetsova N, Leikin S (2002) Type I collagen is thermally unstable at body temperature. Proc Natl Acad Sci USA 99:1314–1318
50. Li J, Brick P, O’Hare MC, Skarzynski T, Lloyd LF, Curry VA, Clark IM, Bigg HF, Hazleman BL, Cawston TE et al (1995) Structure of full-length porcine synovial collagenase reveals a C-terminal domain containing a calcium-linked, four-bladed beta-propeller. Structure 3:541–549
51. Li Z, Hou WS, Br€omme D (2000) Collagenolytic activity of cathepsin K is specifically modulated by cartilage-resident chondroitin sulfates. Biochemistry 39:529–536
52. Li Z, Hou WS, Escalante-Torres CR, Gelb BD, Br€omme D (2002) Collagenase activity of cathepsin K depends on complex formation with chondroitin sulfate. J Biol Chem 277:28669–28676
53. Li Z, Kienetz M, Cherney MM, James MN, Br€omme D (2008) The crystal and molecular structures of a cathepsin K:chondroitin sulfate complex. J Mol Biol 383:78–91
54. Mandl I, Maclennan JD, Howes EL (1953) Isolation and characterization of proteinase and collagenase from Cl. histolyticum. J Clin Invest 32:1323–1329
55. Matsushita O, Jung CM, Katayama S, Minami J, Takahashi Y, Okabe A (1999) Gene duplication and multiplicity of collagenases in Clostridium histolyticum. J Bacteriol 181:923–933
56. Matsushita O, Koide T, Kobayashi R, Nagata K, Okabe A (2001) Substrate recognition by the collagen-binding domain of Clostridium histolyticum class I collagenase. J Biol Chem 276:8761–8770
57. Mitchell PG, Magna HA, Reeves LM, Lopresti-Morrow LL, Yocum SA, Rosner PJ, Geoghegan KF, Hambor JE (1996) Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest 97:761–768
58. Morgunova E, Tuuttila A, Bergmann U, Isupov M, Lindqvist Y, Schneider G, Tryggvason K (1999) Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed. Science 284:1667–1670
59. Murphy G, McAlpine CG, Poll CT, Reynolds JJ (1985) Purification and characterization of a bone metalloproteinase that degrades gelatin and types IV and V collagen. Biochim Biophys Acta 831:49–58
60. Murphy G, Allan JA, Willenbrock F, Cockett MI, O’Connell JP, Docherty AJP (1992) The role of the C-terminal domain in collagenase and stromelysin specificity. J Biol Chem 267:9612–9618
61. Murphy G, Nguyen Q, Cockett MI, Atkinson SJ, Allan JA, Knight CG, Willenbrock F, Docherty AJP (1994) Assessment of the role of the fibronectin-like domain of gelatinase A by analysis of a deletion mutant. J Biol Chem 269:6632–6636
62. Nagai Y, Lapiere CM, Gross J (1966) Tadpole collagenase. Preparation and purification. Biochemistry 5:3123–3130
63. Nagase H (2001) Substrate specificity of MMPs. In: Clendeninn NJ, Appelt K (eds) Matrix metalloproteinase inhibitors in cancer therapy. Humana, Totowa, NJ, pp 39–66
64. Nerenberg PS, Stultz CM (2008) Differential unfolding of alpha1 and alpha2 chains in type I collagen and collagenolysis. J Mol Biol 382:246–256
65. Nerenberg PS, Salsas-Escat R, Stultz CM (2008) Do collagenases unwind triple-helical collagen before peptide bond hydrolysis? Reinterpreting experimental observations with mathematical models. Proteins 70:1154–1161
66. O’Farrell TJ, Guo R, Hasegawa H, Pourmotabbed T (2006) Matrix metalloproteinase-1 takes advantage of the induced fit mechanism to cleave the triple-helical type I collagen molecule. Biochemistry 45:15411–15418
67. Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, Okada Y (1997) Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem 272:2446–2451
68. Okada Y, Nagase H, Harris ED Jr (1986) A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components. Purification and characterization. J Biol Chem 261:14245–14255
69. Okamoto T, Akaike T, Sawa T, Miyamoto Y, van der Vliet A, Maeda H (2001) Activation of matrix metalloproteinases by peroxynitrite-induced protein S-glutathiolation via disulfide S-oxide formation. J Biol Chem 276:29596–29602
70. Orgel JP, Irving TC, Miller A, Wess TJ (2006) Microfibrillar structure of type I collagen in situ. Proc Natl Acad Sci USA 103:9001–9005
71. Ottl J, Gabriel D, Murphy G, Kn€auper V, Tominaga Y, Nagase H, Kroger M, Tschesche H, Bode W, Moroder L (2000) Recognition and catabolism of synthetic heterotrimeric collagen peptides by matrix metalloproteinases. Chem Biol 7:119–132
72. Overall CM (2002) Molecular determinants of metalloproteinase substrate specificity: matrix metalloproteinase substrate binding domains, modules, and exosites. Mol Biotechnol 22:51–86
73. Parry DAD, Craig AS (1984) Growth and development of collagen fibrils in connective tissue. In: Ruggeri A, Motta PM (eds) Ultrastructure of the connective tissue matrix. Springer, Nijhoff Boston, pp 34–64
74. Patterson ML, Atkinson SJ, Kn€auper V, Murphy G (2001) Specific collagenolysis by gelatinase A, MMP-2, is determined by the hemopexin domain and not the fibronectin-like domain. FEBS Lett 503:158–162
75. 0 subsite of matrix metalloproteinase 8 (MMP-8): the role of hydrogen bonding potential of ASN188 and TYR189 and the connecting cis bond. J Biol Chem 280:2370–2377
76. Perona JJ, Tsu CA, Craik CS, Fletterick RJ (1997) Crystal structure of an ecotin-collagenase complex suggests a model for recognition and cleavage of the collagen triple helix. Biochemistry 36:5381–5392
77. Perumal S, Antipova O, Orgel JP (2008) Collagen fibril architecture, domain organization, and triple-helical conformation govern its proteolysis. Proc Natl Acad Sci USA 105:2824–2829
78. Ramachandran GN, Kartha G (1955) Structure of collagen. Nature 176:593–595
79. Reinemer P, Grams F, Huber R, Kleine T, Schnierer S, Piper M, Tschesche H, Bode W (1994) Structural implications for the role of the N terminus in the ‘superactivation’ of collagenases. A crystallographic study. FEBS Lett 338:227–233
80. Rich A, Crick FH (1961) The molecular structure of collagen. J Mol Biol 3:483–506
81. Sabeh F, Ota I, Holmbeck K, Birkedal-Hansen H, Soloway P, Balbin M, López-Otín C, Shapiro S, Inada M, Krane S, Allen E, Chung D, Weiss SJ (2004) Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP. J Cell Biol 167:769–781
82. Saffarian S, Collier IE, Marmer BL, Elson EL, Goldberg G (2004) Interstitial collagenase is a Brownian ratchet driven by proteolysis of collagen. Science 306:108–111
83. Saftig P, Hunziker E, Wehmeyer O, Jones S, Boyde A, Rommerskirch W, Moritz JD, Schu P, von Figura K (1998) Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-Kdeficient mice. Proc Natl Acad Sci USA 95:13453–13458
84. Salsas-Escat R, Nerenberg PS, Stultz CM (2010) Cleavage Site Specificity and Conformational Selection in Type I Collagen Degradation. Biochemistry 49:4147–4158
85. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M (1994) A matrix metalloproteinase expressed on the surface of invasive tumour cells [see comments]. Nature 370:61–65
86. Sato H, Kinoshita T, Takino T, Nakayama K, Seiki M (1996) Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2. FEBS Lett 393:101–104
87. Shipley JM, Doyle GA, Fliszar CJ, Ye QZ, Johnson LL, Shapiro SD, Welgus HG, Senior RM (1996) The structural basis for the elastolytic activity of the 92-kDa and 72-kDa gelatinases. Role of the fibronectin type II-like repeats. J Biol Chem 271:4335–4341
88. Spurlino JC, Smallwood AM, Carlton DD, Banks TM, Vavra KJ, Johnson JS, Cook ER, Falvo J, Wahl RC, Pulvino TA et al (1994) 1.56 A structure of mature truncated human fibroblast collagenase. Proteins 19:98–109
89. Steffensen B, Wallon UM, Overall CM (1995) Extracellular matrix binding properties of recombinant fibronectin type II-like modules of human 72-kDa gelatinase/type IV collagenase. High affinity binding to native type I collagen but not native type IV collagen. J Biol Chem 270:11555–11566
90. Sternlicht MD, Werb Z (2001) How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17:463–516
91. Stricker TP, Dumin JA, Dickeson SK, Chung L, Nagase H, Parks WC, Santoro SA (2001) Structural analysis of the alpha(2) integrin I domain/procollagenase-1 (matrix metalloproteinase-1) interaction. J Biol Chem 276:29375–29381
92. Stultz CM (2002) Localized unfolding of collagen explains collagenase cleavage near imino-poor sites. J Mol Biol 319:997–1003
93. Suzuki K, Enghild JJ, Morodomi T, Salvesen G, Nagase H (1990) Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin). Biochemistry 29:10261–10270
94. Sweeney SM, Orgel JP, Fertala A, McAuliffe JD, Turner KR, Di Lullo GA, Chen S, Antipova O, Perumal S, Ala-Kokko L, Forlino A, Cabral WA, Barnes AM, Marini JC, San Antonio JD (2008) Candidate cell and matrix interaction domains on the collagen fibril, the predominant protein of vertebrates. J Biol Chem 283:21187–21197
95. Toyoshima T, Matsushita O, Minami J, Nishi N, Okabe A, Itano T (2001) Collagen-binding domain of a Clostridium histolyticum collagenase exhibits a broad substrate spectrum both in vitro and in vivo. Connect Tissue Res 42:281–290
96. Tsu CA, Perona JJ, Schellenberger V, Turck CW, Craik CS (1994) The substrate specificity of Uca pugilator collagenolytic serine protease 1 correlates with the bovine type I collagen cleavage sites. J Biol Chem 269:19565–19572
97. Tsukada H, Pourmotabbed T (2002) Unexpected crucial role of residue 272 in substrate specificity of fibroblast collagenase. J Biol Chem 277:27378–27384
98. Van Wart HE, Birkedal-Hansen H (1990) The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Natl Acad Sci USA 87:5578–5582
99. Van Wart HE, Steinbrink DR (1985) Complementary substrate specificities of class I and class II collagenases from Clostridium histolyticum. Biochemistry 24:6520–6526
100. Welgus HG, Grant GA (1983) Degradation of collagen substrates by a trypsin-like serine protease from the fiddler crab Uca pugilator. Biochemistry 22:2228–2233
101. Welgus HG, Jeffrey JJ, Stricklin GP, Roswit WT, Eisen AZ (1980) Characteristics of the action of human skin fibroblast collagenase on fibrillar collagen. J Biol Chem 255:6806–6813
102. Welgus HG, Jeffrey JJ, Eisen AZ (1981a) The collagen substrate specificity of human skin fibroblast collagenase. J Biol Chem 256:9511–9515
103. Welgus HG, Jeffrey JJ, Eisen AZ (1981b) Human skin fibroblast collagenase. Assessment of activation energy and deuterium isotope effect with collagenous substrates. J Biol Chem 256:9516–9521
104. Welgus HG, Grant GA, Jeffrey JJ, Eisen AZ (1982) Substrate specificity of the collagenolytic serine protease from Uca pugilator: studies with collagenous substrates. Biochemistry 21: 5183–5189
105. Welgus HG, Jeffrey JJ, Eisen AZ, Roswit WT, Stricklin GP (1985) Human skin fibroblast collagenase: interaction with substrate and inhibitor. Coll Relat Res 5:167–179
106. Willenbrock F, Crabbe T, Slocombe PM, Sutton CW, Docherty AJP, Cockett MI, O’Shea M, Brocklehurst K, Phillips IR, Murphy G (1993) The activity of the tissue inhibitors of metalloproteinases is regulated by C-terminal domain interactions: a kinetic analysis of the inhibition of gelatinase A. Biochemistry 32:4330–4337
107. Wilson JJ, Matsushita O, Okabe A, Sakon J (2003) A bacterial collagen-binding domain with novel calcium-binding motif controls domain orientation. EMBO J 22:1743–1752
108. Woessner JF Jr (1998) The matrix metalloproteinase family. In: Parks WC, Mecham RP (eds) Matrix metalloproteinases. Academic, San Diego, pp 1–14
109. Woessner JF, Nagase H (2000) Matrix metalloproteinases and TIMPs: protein profile. Oxford University Press, Oxford
110. Wolf K, Mazo I, Leung H, Engelke K, von Andrian UH, Deryugina EI, Strongin AY, Brocker EB, Friedl P (2003) Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J Cell Biol 160:267–277
111. Wolf K, Wu YI, Liu Y, Geiger J, Tam E, Overall C, Stack MS, Friedl P (2007) Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion. Nat Cell Biol 9:893–904
112. Woolley DE, Glanville RW, Crossley MJ, Evanson JM (1975) Purification of rheumatoid synovial collagenase and its action on soluble and insoluble collagen. Eur J Biochem 54:611–622
113. Wu JJ, Lark MW, Chun LE, Eyre DR (1991) Sites of stromelysin cleavage in collagen types II, IX, X, and XI of cartilage. J Biol Chem 266:5625–5628
114. Yañez-Mó M, Barreiro O, Gonzalo P, Batista A., Megías D, Genís L, Sachs N, Sala-Valdés M, Alonso MA, Montoya MC, Sonnenberg A, Arroyo AG, Sánchez-Madrid F (2008) MT1-MMP collagenolytic activity is regulated through association with tetraspanin CD151 in primary endothelial cells. Blood 112:3217–3226